Head and Neck Neoplasms: all 2,403 studies

Page 17 of 25. Open to participants first (559), then studies with results posted, then the rest; newest registration first within each.

• Carcinologic Speech Severity IndexCompletedNCT02875795Not applicable
• Tertiary Prevention of Head and Neck Cancer With a Dietary InterventionCompletedNCT02869399Not applicable
• Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional GastrostomyCompletedNCT02869321Phase 4
• Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck CancersCompletedNCT02868151Phase 2/3
• Study of Copper Isotope in Head and Neck CancerStatus unknownNCT02864836
• Frequency of Xerostomia and Their Management in Upper Aerodigestive Tract Cancer Patients After the End of RadiotherapyCompletedNCT02857413
• Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) OperableCompletedNCT02855723Not applicable
• Total Body Composition in Detection of Nutrition Depletion in Head and Neck PatientsStatus unknownNCT02854735
• ACT for Distress in Head and Neck Cancer PatientsStatus unknownNCT02840071Not applicable
• Oncogeriatric Intervention and Follow-up at HomeStatus unknownNCT02837679Not applicable
• Big Data and Models for Personalized Head and Neck Cancer Decision Support (BD2Decide)Status unknownNCT02832102
• Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck CancerTerminatedNCT02817113Phase 1
• Ipilimumab for Head and Neck Cancer PatientsActive, not recruitingNCT02812524Phase 1
• Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck CancerCompletedNCT02794675Early Phase 1
• Nutrition and Quality of Life of Patients With Head and Neck Carcinoma After RadiotherapyTerminatedNCT02789267Not applicable
• Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?CompletedNCT02787187Not applicable
• Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland CarcinomasCompletedNCT02776163Phase 2
• Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and NeckCompletedNCT02776137Phase 2
• Weight Loss and Gastrostomy Tube Care Outcomes in Head and Neck Cancer Patients With Gastrostomy Tube PlacementStatus unknownNCT02775721Not applicable
• Elective Mucosal Irradiation in Head-and-Neck Cancer of Unknown PrimaryStatus unknownNCT02764216Phase 2
• ALDH2 Mutation in Taiwanese Head and Neck CancerStatus unknownNCT02761408
• Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck CancerActive, not recruitingNCT02760667Phase 2
• Effect of Oral Preparation on Bacterial Colonization of the Pharyngeal Mucosa in Surgery of Head and Neck CancerCompletedNCT02753387Phase 3
• Laser Therapy for the Prevention of Radiodermatitis in Head and Neck PatientsCompletedNCT02738268Not applicable
• Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic TherapiesCompletedNCT02724488
• Treatment and Prevention of Middle Ear Morbidity in Head and Neck Cancer Patients Following RadiotherapyCompletedNCT02716376Not applicable
• DNA Repair Enzyme Signature in Head and Neck Cancer (CHEMRAD)CompletedNCT02714920Not applicable
• Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and CanadaCompletedNCT02705833
• Quantitative Endoscopy of H&NCompletedNCT02704169Phase 2
• Measuring the Effect of Radiation Therapy on Patient Activity LevelsTerminatedNCT02694380
• Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot StudyCompletedNCT02678884Not applicable
• Skin/Soft Tissue Elasticity in Head and Neck Cancer Survivors With Lymphedema and FibrosisCompletedNCT02676752
• Feeding Tube in Cancer PatientsWithdrawnNCT02675673Not applicable
• Personalised Postoperative Radiochemotherapy in Patients With Head and Neck CancerCompletedNCT02666885Not applicable
• Cough, Expiratory Training, and Chronic Aspiration After Head and Neck RadiotherapyActive, not recruitingNCT02662907Not applicable
• Head and Neck Cancer Treatment Related DysphagiaWithdrawnNCT02657850
• Phase III Trial of PET/CT vs. CTSurveilance for Head and Neck CancerTerminatedNCT02655068Phase 3
• Therapeutic Resistance Group Exercise Training for Head & Neck Cancer SurvivorsCompletedNCT02647021Not applicable
• Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02643550Phase 1/2
• A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549Status unknownNCT02637531Phase 1
• E10A for the Treatment of Squamous Cell Carcinoma of the Head and NeckStatus unknownNCT02630264Phase 3
• Melatonin Oral Gel for Oral Mucositis in Patients With Head and Neck Cancer Undergoing ChemoradiationCompletedNCT02630004Phase 1/2
• Multi-Modality Imaging for Head & Neck Cancer Free Flap Design AssessmentTerminatedNCT02629029Not applicable
• A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)CompletedNCT02627274Phase 1
• Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and NeckStatus unknownNCT02624128Phase 2
• Comparison of Two Immunomodulatory Formulas on the Number of Postoperative Infections in Head & Neck Cancer PatientsCompletedNCT02622880Phase 4
• 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer PatientsTerminatedNCT02602067Phase 1
• A Feasibility Study to Further the Development of Lung Cancer-based Precision MedicineActive, not recruitingNCT02597738Not applicable
• Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental IllnessCompletedNCT02594696Not applicable
• Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck CancerWithdrawnNCT02593929Early Phase 1
• Building Caregiver Skills Using a Simulation-based Intervention for Care of Head and Neck CancerCompletedNCT02577237Not applicable
• The Effects of Whole Food Intervention on Mucositis in Patients Treated for Head and Neck CancerTerminatedNCT02575313Phase 1/2
• Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free FlapsCompletedNCT02572869
• Mapping of Sentinel Lymph Node Drainage Using SPECT (SUSPECT) (SUSPECT)CompletedNCT02572661Not applicable
• Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)Active, not recruitingNCT02568267Phase 2
• Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck CancerStatus unknownNCT02567383Phase 2
• Bleeding, Cardio- and Cerebrovascular Complications in Head and Neck SurgeryCompletedNCT02563470
• Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and NeckStatus unknownNCT02558387Phase 2
• Progressive Resistance Training in Head and Neck Cancer Patients During Concomitant ChemoradiotherapyTerminatedNCT02557529Not applicable
• A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck CancerCompletedNCT02555644Phase 1
• Reliability and Validity of Patient Reported Outcome Measures in Head and Neck CancerCompletedNCT02554968
• Electrochemotherapy on Head and Neck CancerStatus unknownNCT02549742Phase 2
• Remote Ischemic Preconditioning in Head and Neck Cancer Reconstruction - A Randomized Controlled TrialCompletedNCT02548377Not applicable
• Prospective Registration of Head and Neck CancerCompletedNCT02546895
• Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and ChemotherapyTerminatedNCT02542215Phase 2
• Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer : Interest of an Addiction TreatmentCompletedNCT02540174Not applicable
• Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During ChemoradiationCompletedNCT02531906Phase 1
• De-Intensification Radiotherapy Postoperative Head NeckCompletedNCT02528955Phase 2
• Evaluation of the Contribution of Transoral Robotic-assisted Surgery Using Da Vinci Xi for Head and Neck TumorsCompletedNCT02517125Not applicable
• Can DW MRI Predict Outcome During Radiotherapy for Head and Neck Cancer?Status unknownNCT02497573
• Predictive Models for Radiation-induced Side Effects in Head and Neck Cancer Based on Single Nucleotide Polymorphisms (SNP)CompletedNCT02489084
• Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing ChemoradiotherapyTerminatedNCT02485470Phase 2
• Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) TherapyCompletedNCT02484677Phase 4
• Study of the CD40 Agonistic Monoclonal Antibody APX005MCompletedNCT02482168Phase 1
• Sentinel Lymph Node Mapping of Oral Cancer Using Near-Infrared Fluorescence ImagingCompletedNCT02478138Not applicable
• Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and NeckActive, not recruitingNCT02474368Phase 1
• A Window of Opportunity Study of KTN3379 in Surgically Resectable Head and Neck Cancer PatientsCompletedNCT02473731Phase 1
• Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological CancerCompletedNCT02469922Not applicable
• Palliative Radiotherapy Protocol in Head and Neck CancerCompletedNCT02460471Phase 2
• Hyperbaric Oxygen and Its Effect on Radiation Induced Long Term Side EffectsCompletedNCT02450305
• Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary HypofunctionCompletedNCT02446249Phase 1
• Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck CancersWithdrawnNCT02442739Early Phase 1
• Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation ToxicityCompletedNCT02442375Phase 3
• Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer DiagnosticsStatus unknownNCT02441972Phase 1
• Rehabilitation for Head and Neck CancerCompletedNCT02439892Not applicable
• Paracetamol With or Without Ketoprofen in the Management of Pain for Patients Receiving Brachytherapy (KETOCOL-1304)CompletedNCT02439034Phase 2
• The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck CancersCompletedNCT02435602Not applicable
• Topical/Oral Melatonin for Preventing Concurrent Radiochemotherapy Induced Oral Mucositis/Xerostomia Cancer PatientsCompletedNCT02430298Phase 2
• P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck CancerStatus unknownNCT02429037Phase 2
• In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®CompletedNCT02423863Phase 2
• Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck CancerCompletedNCT02422979Phase 1/2
• Comparing Two Palliative Schemes of Radiotherapy for Head and Neck CancerTerminatedNCT02421458Not applicable
• Evaluation of Intraoperative Usage of Sentinella in Detecting Sentinel Lymph NodesCompletedNCT02416336Not applicable
• Panitumumab IRDye800 Optical Imaging StudyCompletedNCT02415881Phase 1
• Hypoxia Analysis in Head and/or Neck CancerStatus unknownNCT02414048Phase 2
• Improving Self-Management in Head and Neck CancerCompletedNCT02409485Not applicable
• Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and AnoikisTerminatedNCT02402348Early Phase 1
• The Impact of Pentoxifylline and Vitamin E on Radiotherapy-induced Toxicity in Head & Neck Cancer PatientsCompletedNCT02397486Phase 2
• Prospective, Observational, Real-world Oral Malignant Tumors StudyCompletedNCT02395367
• Safety, Immunogenicity and Pharmacokinetics of SYN004 in Patients With Solid TumorsCompletedNCT02391727Phase 1

← Head and Neck Neoplasms overview